Jörn M. Schattenberg is a Professor of Medicine and Director of the Department of Medicine II at the Saarland University Medical Center in Homburg and the University of the Saarland in Germany. He received his medical degree in 2002 after studying at the University of Mainz (Germany) and at the Tulane University in New Orleans (US).

Rotonya McCants Carr, MD is the Cyrus E. Rubin Chair and Division Head of Gastroenterology at the University of Washington. She is a basic science researcher and clinical hepatologist who specializes in the care of patients with fatty liver diseases. Her laboratory uses complementary in vivo and cellular approaches to investigate the mechanisms of insulin resistance in metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and alcohol-associated liver disease (ALD). Dr.

Dr. Rohit Loomba is a Professor of Medicine (with tenure), Chief, Division of Gastroenterology and Hepatology, at the University of California at San Diego. He is an internationally recognized thought leader in translational research and innovative clinical trial design in nonalcoholic steatohepatitis (NASH), and non-invasive assessment of liver disease using advanced imaging modalities. <br>Dr.

Mary E. Rinella, MD<br>Dr. Rinella is currently Professor of Medicine in the Gastroenterology, Hepatology and Nutrition section at the University of Chicago since January 2021. She is the director of the Metabolic and Fatty Liver Program as well as Director of Clinical trials for the section. <br>She has held several leadership roles, including on the Governing Board of the American Association for the Study of Liver Disease (AASLD) and chaired numerous upper level national committees.

Debbie Shawcross is a Clinician Scientist and Professor of Hepatology and Chronic Liver Failure at the Institute of Liver Studies and James Black Centre, King's College London. She works as a Consultant Hepatologist on the King's Liver Unit with a specialist interest in hepatic encephalopathy, liver failure syndromes and the complications of cirrhosis.

Dr. Arab is an Associate Professor of Medicine at the Division of Gastroenterology, Hepatology, and Nutrition of Virginia Commonwealth University School of Medicine. He serves as the Inaugural Director of Alcohol Sciences at the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. Dr. Arab trained as Gastroenterologist and Transplant Hepatologist specialist at the Catholic University of Chile and at the Mayo Clinic, Rochester, MN. Dr.

Mazen Noureddin, MD, MHSc, did his internal medicine residency at the University of Southern California (USC) and then moved to the National Institutes of Health (NIH), where he enrolled in a three-year hepatology fellowship at the Liver Diseases Branch of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). There, he finished the NIH/Duke University Master of Health Sciences in Clinical Research program. After completing his NIH fellowship, he completed a gastroenterology fellowship at the University of California, San Diego (UCSD), where he was a T32 NIH fellow.

Aleksander Krag, MD, PhD, MBA is Professor and Department Chair, Department of Gastroenterology and Hepatology Odense University Hospital, Director of Centre for Liver Research (FLASH) Odense University Hospital and DIAS Chair of Health Sciences, University of Southern Denmark. He also served as Vice-Secretary and then as Secretary General of European Association for the Study of Liver (EASL) 2021-2025.

H. Marvin Pollard Collegiate Professor of Gastroenterology III<br>Professor of Internal Medicine and Surgery<br>Director, Morphomics Analysis Group<br>University of Michigan Medical School<br><br>Chief, Gastroenterology and Hepatology Section<br>Associate Chief of Specialty Care and Access, Medicine Service<br>VA Ann Arbor Healthcare System

Teresa (Terry) Wright is currently Vice President and Clinical Research Head for Hepatology at GSK with responsibility for oversight of clinical development of investigational agents for patients with viral, metabolic and autoimmune liver diseases.<br>Terry started her hepatology training while a medical resident at Johns Hopkins Hospital under the watchful eyes of Willis Maddrey (past-president of AASLD) and Mack Mitchell, followed by gastroenterology/hepatology fellowship at UCSF where Rudi Schmid and Tom Boyer (both past presidents of AASLD) were mentors.